Patient access department employees have been receiving the COVID-19 vaccine. To avoid staffing shortfalls, leaders have been staggering shifts in case anyone who has received the vaccine experiences side effects that would keep them out of work.

Clinicians can use new monoclonal antibody therapies to treat high-risk patients presenting with mild to moderate COVID-19 symptoms. However, despite the promise to depress viral loads, logistical and other challenges continue to stand in the way of larger-scale use. Still, some EDs are trying the therapeutics, with promising results.